While the company's shares fell by as much as 17% on Tuesday, this setback turned up the risk meter a few notches for the pharmaceutical sector. Stocks such as Sun Pharmaceutical Industries Ltd and Dr Reddy's Laboratories Ltd that have pending regulatory issues all fell on Tuesday. If investors had thought maybe the worst is over, these developments were a rude wake-up call.